TL;DR
This study investigated the prevalence and spectrum of mutations in the OPA1 gene, a common cause of dominant optic atrophy (DOA), in 193 Chinese families. They identified 11 OPA1 mutations (8 novel) in 6.2% of families, suggesting a lower frequency of OPA1-related DOA in Chinese populations compared to Caucasians, potentially due to a lack of awareness of its milder phenotypes.
What Problem Does This Paper Address?
Dominant optic atrophy (DOA) is a significant cause of inherited vision loss, primarily linked to mutations in the OPA1 gene. While DOA is considered the most common form of hereditary optic neuropathy, its prevalence and the specific mutations involved can vary across ethnic groups. Previous studies on OPA1 mutations have largely focused on Caucasian populations, leaving a knowledge gap regarding its frequency and mutational landscape in Asian populations, particularly in China. This study aims to address this by systematically screening Chinese families with suspected hereditary optic neuropathy for OPA1 gene mutations, providing crucial data for understanding DOA epidemiology and facilitating genetic diagnosis in this demographic.
Methods
The researchers employed Sanger sequencing to analyze the coding regions and adjacent intronic regions of the OPA1 gene in 193 Chinese families. These families had been previously screened and excluded for the three common mitochondrial DNA mutations associated with Leber hereditary optic neuropathy (LHON). Genomic DNA was extracted from peripheral blood leukocytes. PCR amplification was performed using 30 primer sets designed to cover exon-intron junctions, followed by sequencing. Novel mutations were further evaluated for their potential pathogenicity using computational prediction tools (Blosum62, PolyPhen-2, SIFT) and evolutionary conservation analysis. Segregation analysis was conducted in families with identified mutations to confirm their inheritance patterns.
Datasets
The study utilized a cohort of 193 Chinese families with suspected hereditary optic neuropathy. A control group of 192 healthy individuals was also included for mutation screening.
Key Insights and Ideas
- Lower DOA Frequency in Chinese Populations: The study found a significantly lower frequency of OPA1 mutations (6.2%) in Chinese families compared to reported frequencies in Caucasian populations (around 30%). This suggests that DOA might be less prevalent or less frequently diagnosed in China.
- Potential for Underdiagnosis: The authors hypothesize that a lack of awareness regarding the milder, sometimes asymptomatic, phenotypes of DOA might contribute to its lower reported frequency in China. This highlights the importance of considering DOA even in individuals with subtle visual impairments.
- Novel Mutations Identified: Eight out of the 11 identified OPA1 mutations were novel, expanding the known spectrum of genetic alterations associated with DOA.
- Compound Heterozygosity and Additive Effects: The study identified a rare case of compound heterozygosity for two OPA1 mutations in a young boy, who presented with a more severe phenotype than his parents, each carrying one of the mutations. This suggests a potential additive effect of multiple OPA1 mutations, leading to a more pronounced clinical presentation.
- Possible Ethnic-Specific Mutation Hotspots: While not definitively established due to the sample size, the discovery of three novel mutations within a small region around the 5' end of exon 10 hints at a potential mutational hotspot in this region for Chinese populations.
Key Results
- OPA1 mutations were identified in 12 out of 193 families (6.2%).
- Of these, 8 mutations were novel, and 3 were previously reported.
- The identified mutations included nonsense, missense, deletion, insertion, and splice site mutations.
- The c.2708_2711del mutation in exon 27 was found in 25% of the mutation-positive families, confirming its status as a mutational hotspot.
- In two sporadic cases, segregation analysis revealed that one parent in each family carried an OPA1 mutation and exhibited a mild phenotype, suggesting incomplete penetrance or variable expressivity.
- A 4-year-old boy with compound heterozygous OPA1 mutations (c.190_194del and c.1129G>A) presented with severe vision loss, while his father (carrying the deletion) and mother (carrying the missense mutation) had milder or asymptomatic phenotypes.
Limitations and Future Work
The authors acknowledge that the study's sample size for OPA1 mutations is relatively small, limiting the ability to definitively identify ethnic-specific mutational hotspots. They suggest that further molecular epidemiological studies with larger cohorts are needed to fully understand the prevalence and spectrum of OPA1 mutations in Asian populations. Additionally, they recommend continued investigation into the genotype-phenotype correlations, especially concerning compound heterozygosity and the impact of modifier alleles, to improve diagnostic accuracy and genetic counseling for patients with hereditary optic neuropathies. The potential role of environmental factors, such as antituberculosis medication, in exacerbating visual deterioration in patients with OPA1 mutations also warrants further exploration.
Summary updated